Impax Laboratories Inc. said Thursday that the Food and Drug Administration hasn’t yet inspected a Hayward factory and that approvals of some drugs may be held up as a result.
Hayward-based Impax (NASDAQ: IPXL) got a warning letter from the FDA last year about the way drugs are sampled and tested at the factory.
Although it is still able to use the factory - the FDA didn’t shut it down - the downcheck can affect approval of drugs that list the factory as a manufacturing site.
No comments:
Post a Comment